Recherche
-
Epidemics and outbreaks of peripheral nervous system disorders: II. Toxic and nutritional causes
(Journal of Neurology. vol. 268, n° 3, pp. 892-902, 2021-03)Article de revue -
(Re)contextualizing the Trauma to Prevent or Treat PTSD-Related Hypermnesia
(Chronic Stress. vol. 5, 2021-05-26)Article de revueLibre accès -
Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis.
(Neurobiology of Disease. vol. 160, pp. 105533, 2021-12-01)Article de revueLibre accès -
CB1 and GLP-1 Receptors Cross Talk Provides New Therapies for Obesity
(Diabetes. vol. 70, n° 2, pp. 415-422, 2021-02)Article de revue -
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
(CNS drugs. vol. 35, n° 11, pp. 1217-1232, 2021-11)Article de revue -
Olfaction and anosmia: From ancient times to COVID-19
(Journal of the Neurological Sciences. vol. 425, 2021-06-15)Article de revueLibre accès -
Identification of BiP as a CB1 receptor-interacting protein that fine-tunes cannabinoid signaling in the mouse brain
(Journal of Neuroscience. vol. 41, n° 38, pp. 7924-7941, 2021-09-22)Article de revueLibre accès -
Communication and social interaction in the cannabinoid-type 1 receptor null mouse: Implications for autism spectrum disorder
(Autism Research. vol. 14, n° 9, pp. 1854-1872, 2021-09)Article de revueLibre accès -
Breathing-driven prefrontal oscillations regulate maintenance of conditioned-fear evoked freezing independently of initiation
(Nature Communications. vol. 12, n° 1, 2021-05-10)Article de revueLibre accès -
A meta-analysis comparing first-line immunosuppressants in neuromyelitis optica
(Annals of Clinical and Translational Neurology. vol. 8, n° 10, pp. 2025-2037, 2021-10)Article de revueLibre accès